Literature DB >> 33947008

Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy.

Francesco Napolitano1, Gabriella Di Giuseppe1, Maria Vittoria Montemurro2, Anna Maria Molinari3, Giovanna Donnarumma1, Antonio Arnese1, Maria Pavia1, Italo Francesco Angelillo1.   

Abstract

BACKGROUND: This study was carried out to estimate the seroprevalence of SARS-CoV-2 antibodies in a Southern Italian population.
METHODS: The study was performed among students and workers of the University of Campania "Luigi Vanvitelli" and the relative Teaching Hospital. Participants were invited to undergo a blood sampling, an interview or to complete a self-administered questionnaire.
RESULTS: A total of 140 participants (5.8%) tested positive for SARS-CoV-2 antibodies. Positive SARS-CoV-2 test results increased significantly during the months of testing, and those who had had at least one symptom among fever, cough, dyspnea, loss of taste or smell and who had had contact with a family member/cohabitant with confirmed COVID-19 were more likely to test positive. Faculty members were less likely to have a positive test result compared to the healthcare workers (HCWs). Among HCWs, physicians showed the lowest rate of seroconversion (5.2%) compared to nurses (8.9%) and other categories (10%). Nurses and other HCWs compared to the physicians, those who had had at least one symptom among fever, cough, dyspnea, loss of taste or smell, and who had had contact with a family member/cohabitant with confirmed COVID-19 were more likely to test positive.
CONCLUSIONS: The results have demonstrated that SARS-CoV-2 infection is rapidly spreading even in Southern Italy and confirm the substantial role of seroprevalence studies for the assessment of SARS-CoV-2 infection circulation and potential for further spreading.

Entities:  

Keywords:  Italy; SARS-CoV-2 antibodies; adults; healthcare workers; seroprevalence

Mesh:

Year:  2021        PMID: 33947008     DOI: 10.3390/ijerph18094761

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  12 in total

1.  Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy.

Authors:  Stefania Paduano; Pasquale Galante; Nausicaa Berselli; Luca Ugolotti; Alberto Modenese; Alessandro Poggi; Marcella Malavolti; Sara Turchi; Isabella Marchesi; Roberto Vivoli; Paola Perlini; Rossana Bellucci; Fabriziomaria Gobba; Marco Vinceti; Tommaso Filippini; Annalisa Bargellini
Journal:  Int J Environ Res Public Health       Date:  2022-06-27       Impact factor: 4.614

2.  SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021.

Authors:  Avula Laxmaiah; Nalam Madhusudhan Rao; N Arlappa; Jagjeevan Babu; P Uday Kumar; Priya Singh; Deepak Sharma; V Mahesh Anumalla; T Santhosh Kumar; R Sabarinathan; M Santhos Kumar; R Ananthan; D Anwar Basha; P P S Blessy; D Chandra Kumar; P Devaraj; S Devendra; M Mahesh Kumar; Indrapal I Meshram; B Naveen Kumar; Paras Sharma; P Raghavendra; P Raghu; K Rajender Rao; P Ravindranadh; B Santosh Kumar; G Sarika; J Srinivasa Rao; M V Surekha; F Sylvia; Deepak Kumar; G Subba Rao; Karthik Bharadwaj Tallapaka; Divya Tej Sowpati; Surabhi Srivastava; V Manoj Murhekar; Rajkumar Hemalatha; Rakesh K Mishra
Journal:  IJID Reg       Date:  2021-11-19

3.  Seroprevalence and risk factors for COVID-19 in the metropolis of the Brazilian Amazon.

Authors:  Maria Karoliny da Silva Torres; Felipe Teixeira Lopes; Aline Cecy Rocha de Lima; Carlos Neandro Cordeiro Lima; Wandrey Roberto Dos Santos Brito; Bernardo Cintra Dos Santos; Renata Santos de Sousa; Jayanne Lilian Carvalho Gomes; Bruno José Sarmento Botelho; Ana Carolina Alves Correa; Luiz Fernando A Machado; Rosimar Neris Martins Feitosa; Sandra Souza Lima; Izaura Maria Vieira Cayres Vallinoto; Antonio Carlos R Vallinoto
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

4.  Prevalence of SARS-CoV-2 Infection in a Sample of Health Workers in Two Health Departments of the Valencian Community in Spain.

Authors:  Kenan Rodríguez de Limia Ramírez; Nicolás Ruiz-Robledillo; José Luis Duro-Torrijos; Vicente García-Román; Natalia Albaladejo-Blázquez; Rosario Ferrer-Cascales
Journal:  Int J Environ Res Public Health       Date:  2021-12-22       Impact factor: 3.390

5.  A cross sectional study found differential risks for COVID-19 seropositivity amongst health care professionals in Chile.

Authors:  Marcela Zuñiga; Anne J Lagomarcino; Sergio Muñoz; Alfredo Peña Alonso; María Andrea Rodriguez; Miguel L O'Ryan
Journal:  J Clin Epidemiol       Date:  2021-12-26       Impact factor: 6.437

6.  Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population.

Authors:  Rosa Papadopoli; Caterina De Sarro; Caterina Palleria; Luca Gallelli; Claudia Pileggi; Giovambattista De Sarro
Journal:  Vaccines (Basel)       Date:  2021-12-17

7.  Sero-prevalence of SARS-CoV-2 in certain cities of Kazakhstan.

Authors:  Manar Smagul; Aizhan Esmagambetova; Gauhar Nusupbaeva; Ulyana Kirpicheva; Lena Kasabekova; Gauhar Nukenova; Timur Saliev; Ildar Fakhradiyev; Shynar Tanabayeva; Baurzhan Zhussupov
Journal:  Health Sci Rep       Date:  2022-03-15

8.  Assessment of SARS-CoV-2 Infection among Healthcare Workers of a German COVID-19 Treatment Center.

Authors:  Lionel Larribère; Jelizaveta Gordejeva; Lisa Kuhnhenn; Maximilian Kurscheidt; Monika Pobiruchin; Dilyana Vladimirova; Maria Martin; Markus Roser; Wendelin Schramm; Uwe M Martens; Tatjana Eigenbrod
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

9.  Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population.

Authors:  George Krashias; Elie Deeba; Astero Constantinou; Maria Hadjiagapiou; Dana Koptides; Jan Richter; Christina Tryfonos; Stavros Bashiardes; Anastasia Lambrianides; Maria A Loizidou; Andreas Hadjisavvas; Mihalis I Panayiotidis; Christina Christodoulou
Journal:  Microorganisms       Date:  2021-12-31

10.  SARS-CoV-2 Seroprevalence in Western Romania, March to June 2021.

Authors:  Tudor Rares Olariu; Alina Cristiana Craciun; Daliborca Cristina Vlad; Victor Dumitrascu; Iosif Marincu; Maria Alina Lupu
Journal:  Medicina (Kaunas)       Date:  2021-12-26       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.